catechin and Barrett Esophagus

catechin has been researched along with Barrett Esophagus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdul, K; Abrams, JA; Ahmed, A; Akpa, E; Bigg, M; Bresalier, RS; Brown, PH; Cheung, K; Foreman, J; Friedman, RA; Hibshoosh, H; Joe, AK; Lee, JJ; Lightdale, CJ; Lippman, SM; Liu, DD; Milne, GL; Neugut, AI; Perloff, M; Schnoll-Sussman, F; Su, T; Wang, X; Yang, CS1
Bresalier, RS; Krishnan, K; Liu, K; Song, S1

Trials

1 trial(s) available for catechin and Barrett Esophagus

ArticleYear
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:12

    Topics: Aged; Aged, 80 and over; Barrett Esophagus; Biopsy; Catechin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Esophagoscopy; Female; Humans; Male; Middle Aged; Phytotherapy

2015

Other Studies

1 other study(ies) available for catechin and Barrett Esophagus

ArticleYear
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Barrett Esophagus; Catechin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Phosphorylation; Proteasome Endopeptidase Complex; Tea

2009